Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 12, 2025

WENDEL: Wendel Investor Day

View original at globenewswire.com
WENDEL: Wendel Investor Day Wendel's transformation: two powerful value creation engines expected to generate more than €7 billion in cash flow by end 2030 and to return at least €1.6 billion to shareholders Cancellation of 3.8% of treasury shares and launch of a share buyback representing 9% of the share capital in 20…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • WPI direct control investments target approximately €300 million per year per investment, potentially alongside co-investors investing similar amounts

    80% confidence
  • Around €1.7 billion will be invested in Wendel Principal Investments (WPI) by 2030

    80% confidence
  • Wendel will maintain its Investment Grade credit rating and manage leverage prudently

    80% confidence
  • WPI targets average annual increase in intrinsic value of 12% to 16%

    80% confidence
  • Wendel expects to generate more than €7 billion in cash flow by end 2030 and to return at least €1.6 billion to shareholders

    80% confidence
  • By end 2030, the asset management business is expected to represent more than half of Wendel's intrinsic value

    80% confidence
  • WIM is expected to generate annual FRE in excess of €200 million in 2026 on a pro forma basis following acquisition of Committed Advisors

    80% confidence
  • Performance fees (PRE) from next fundraising vintages could represent approximately €300 million

    80% confidence
  • More than €1.6 billion is to be returned to shareholders through dividends and share buybacks by 2030

    80% confidence
  • Wendel has become a global investment firm with a unique model dedicated to private assets in three years

    80% confidence
  • Wendel's recurring cash flows and portfolio proceeds expected to generate solid cash inflow of more than €7 billion by 2030, enabling return of more than €1.6 billion to shareholders

    80% confidence
  • Cumulative ordinary dividends expected to represent approximately €1.3 billion returned to shareholders by end 2030

    80% confidence
  • More than €2.5 billion will be invested in the WIM platform by end 2030

    80% confidence
  • Wendel's objective of maintaining at least a stable dividend year-on-year remains unchanged

    80% confidence
  • Remaining balance of more than €1.2 billion will potentially be allocated to additional shareholder returns and/or new investments

    80% confidence
  • WIM targets average organic FRE annual growth of 15% through 2030

    80% confidence
  • Dividend policy based on 2.5% of WPI's NAV plus around 90% of dividend distributed by WIM; medium-term target of ~3.5% of NAV

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com